1.
AlShoaibi I, Abdo B, Abdullah M, Alzanen K, Alhakamy M, Al-Namer M, Al-Hagri A, Salah M, Salem A, Almogahed M, Alnadhari I, Ahmed F. Effect of DOPA decarboxylase inhibitor supplements on the incidence of urinary tract infections in Parkinson’s disease patients: A systematic review and meta-analysis of randomized controlled trials. Arch Ital Urol Androl [Internet]. 2024 Oct. 29 [cited 2024 Nov. 8];. Available from: https://www.pagepressjournals.org/aiua/article/view/12833